Opsoclonus‐myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Opsoclonus‐myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 69, Issue 11, Pages -
Publisher
Wiley
Online
2022-09-12
DOI
10.1002/pbc.29949
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma
- (2021) Soheila Shirinbak et al. OncoImmunology
- Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma
- (2021) Celina L. Szanto et al. Cancers
- Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma
- (2021) Riyue Bao et al. Journal for ImmunoTherapy of Cancer
- Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome
- (2021) Jonathan D. Santoro et al. Neurology-Neuroimmunology & Neuroinflammation
- Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG)
- (2021) Miki Ohira et al. Biomolecules
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group
- (2020) Rajen Mody et al. JOURNAL OF CLINICAL ONCOLOGY
- A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors
- (2020) Michal Slyper et al. NATURE MEDICINE
- Exploration of the molecular characteristics of the tumor–immune interaction and the development of an individualized immune prognostic signature for neuroblastoma
- (2020) Wenyi Jin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma
- (2020) Xu Ding et al. Journal of Neuroinflammation
- Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience
- (2020) Ami Patel et al. PEDIATRIC BLOOD & CANCER
- Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
- (2020) Ombretta Melaiu et al. Nature Communications
- The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
- (2020) Judith Wienke et al. EUROPEAN JOURNAL OF CANCER
- A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
- (2019) Wayne L. Furman et al. CLINICAL CANCER RESEARCH
- Cellular components in tumor microenvironment of neuroblastoma and the prognostic value
- (2019) Xiaodan Zhong et al. PeerJ
- Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T Cell Receptors in High-riskMYCN-not-amplified Human Neuroblastoma
- (2018) Jun S. Wei et al. CLINICAL CANCER RESEARCH
- Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS
- (2018) Michael R. Pranzatelli et al. JOURNAL OF NEUROIMMUNOLOGY
- Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus Syndrome
- (2018) Barbara Hero et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Multifactorial analysis of opsoclonus-myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children
- (2018) Michael R. Pranzatelli et al. PEDIATRIC BLOOD & CANCER
- Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells
- (2018) Gloria Pelizzo et al. BMC CANCER
- BAFF and BAFF-Receptor in B Cell Selection and Survival
- (2018) Cristian R. Smulski et al. Frontiers in Immunology
- Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
- (2017) Rajen Mody et al. LANCET ONCOLOGY
- Clinicopathological features of neuroblastic tumors with opsoclonus-myoclonus-ataxia syndrome: Follicular structure predicts a better neurological outcome
- (2017) Hiroko Fukushima et al. PATHOLOGY INTERNATIONAL
- Invariant natural killer T infiltration in neuroblastoma with favorable outcome
- (2017) Tomoro Hishiki et al. PEDIATRIC SURGERY INTERNATIONAL
- PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective
- (2017) Palanisamy Nallasamy et al. SEMINARS IN CANCER BIOLOGY
- MYCN Amplification Is Associated with Repressed Cellular Immunity in Neuroblastoma: An In Silico Immunological Analysis of TARGET Database
- (2017) Peng Zhang et al. Frontiers in Immunology
- Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study
- (2017) Michael R. Pranzatelli et al. Frontiers in Neurology
- Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression
- (2017) Julian P. Layer et al. OncoImmunology
- Genetic features of neuroblastic tumors associated with opsoclonus-myoclonus syndrome opens up the possibility for detection in peripheral blood
- (2016) Ana P. Berbegall et al. Expert Review of Neurotherapeutics
- Genetic features of neuroblastic tumors associated with opsoclonus-myoclonus syndrome opens up the possibility for detection in peripheral blood
- (2016) Ana P. Berbegall et al. Expert Review of Neurotherapeutics
- A nationwide survey of opsoclonus–myoclonus syndrome in Japanese children
- (2015) Shunji Hasegawa et al. BRAIN & DEVELOPMENT
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma
- (2015) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Autoantibody-mediated cytotoxicity in paediatric opsoclonus–myoclonus syndrome is dependent on ERK-1/2 phophorylation
- (2015) Verena Fühlhuber et al. JOURNAL OF NEUROIMMUNOLOGY
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
- (2015) Marco Mina et al. OncoImmunology
- PD-L1 and CD8+PD1+lymphocytes exist as targets in the pediatric tumor microenvironment for immunomodulatory therapy
- (2015) Ferdousi Chowdhury et al. OncoImmunology
- Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
- (2014) R Defferrari et al. BRITISH JOURNAL OF CANCER
- Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome
- (2013) M. R. Pranzatelli et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity
- (2013) Lizzia Raffaghello et al. JOURNAL OF LEUKOCYTE BIOLOGY
- BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
- (2013) Michael R Pranzatelli et al. Journal of Neuroinflammation
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Update on Pediatric Opsoclonus Myoclonus Syndrome
- (2013) Gudrun Schleiermacher et al. NEUROPEDIATRICS
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
- (2012) Eric Lancaster et al. Nature Reviews Neurology
- Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome
- (2011) Andreas Brunklaus et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Another promising treatment option for neuroblastoma-associated opsoclonus–myoclonus syndrome by oral high-dose dexamethasone pulse: Lymphocyte markers as disease activity
- (2011) Makiko Oguma et al. BRAIN & DEVELOPMENT
- Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
- (2011) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
- (2011) Madhu Gowda et al. Journal of Translational Medicine
- Opsoclonus–myoclonus in children associated or not with neuroblastoma
- (2010) Pauline Krug et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Long-Term Cerebrospinal Fluid and Blood Lymphocyte Dynamics After Rituximab for Pediatric Opsoclonus-Myoclonus
- (2009) Michael R. Pranzatelli et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome
- (2009) V. Fühlhuber et al. JOURNAL OF NEUROIMMUNOLOGY
- Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma
- (2008) Lizzia Raffaghello et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes
- (2008) Eric Kampmann et al. JOURNAL OF NEUROCHEMISTRY
- Immune or inflammatory response by the host brain suppresses neuronal differentiation of transplanted ES cell–derived neural precursor cells
- (2008) Makoto Ideguchi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Chemokines in neuroectodermal cancers: The crucial growth signal from the soil
- (2008) Nicole Gross et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More